Artificial Intelligence is growing rapidly and being used in every field to create new inventions. Similarly, Global Diagnostics Australia (GDA), a subsidiary of the Integral Diagnostics Group (IDX), has incorporated the use of artificial intelligence (AI) into its radiology technology and it is one of the first diagnostic imaging companies to in Australia to adopt it. GDA has collaborated with Aidoc, an AI company to incorporate its algorithms into GDA’s care management pathway. Patient diagnosis and treatment for several head, neck and chest conditions will be accelerated due to the use of AI. It will help improve patients’ experience as well as their convenience.
The AI solution proposed by Aidoc initially analyzes the medical images and prioritizes the patient list to make sure that the most critical are diagnosed and treated firsthand. This Ai solution by Aidioc has been considered a hallmark and has enabled them to expand in Australia.
Aidoc is already on a great start having had their clearance by Therapeutic Goods of Australia (TGA) and has also received approvals from U.S Food and Drug Administration (FDA) as well as European Union CE markings on AI applications for three medical conditions such as intracranial hemorrhage, pulmonary embolism, and cervical-spine fracture.
Alongside onsite hospital radiology services, GDA also provides teleradiology services to remote and rural parts of Western Australia. Using AI to prioritize critical conditions helps accelerate their services when there is a time limit or when the patients need to be transferred to larger facilities in the metropolitan area in case of an emergency.
Nazar Bokani, M.D., clinical director, GDA shared his views that the workload for the radiologists in the region has increased due to the increase in demand for radiology services in the region. With the help of AI, we can effectively identify the urgent cases and this allows the radiologists to prioritize those patients.